<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HB2371</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HB2371 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr><p><b>Sen. David Koehler</b></p><p><b>Filed: 5/28/2025</b></p><p> </p><p> </p><br> </td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><center><code>AMENDMENT TO HOUSE BILL 2371</code></center><br></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>AMENDMENT NO. ______. Amend House Bill 2371, AS AMENDED, </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>by replacing everything after the enacting clause with the </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>following:</code><br> </td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Section 1. </code><code>Short title. </code><code>This Act may be cited as the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Patient Access to Pharmacy Protection Act.</code><br> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 5. </code><code>Findings. </code><code>The General Assembly finds that:</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(1) It is within the traditional authority of the State to </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>regulate the acquisition and delivery of drugs to pharmacies </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>and providers.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(2) The federal 340B statute is silent on distribution of </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>340B-acquired drugs to 340B covered entities and their </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>contract pharmacy partners.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(3) The State's compelling interest in preserving and </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>improving access to health care services requires it to ensure </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>that 340B covered entities continue to be allowed to contract </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>with pharmacies to receive 340B drugs and dispense them to the </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>patients of 340B covered entities in accordance with federal </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>law.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(4) Addressing accessibility of these life-saving </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>medications is a matter of health, safety, and welfare for the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>people of the State of Illinois.</code><br> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 10. </code><code>Definitions. </code><code>As used in this Act:</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B contract pharmacy" means any pharmacy that is under </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>contract with a 340B covered entity to dispense 340B drugs on </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>behalf of the 340B covered entity and is either (i) located in </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>Illinois and qualifies as a pharmacy under Section 3 of the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>Pharmacy Practice Act; or (ii) is located in a state, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>commonwealth, or territory of the United States, other than </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>Illinois, and dispenses 340B drugs on behalf of the 340B </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>covered entity.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B covered entity" means an entity in Illinois that </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>qualifies as a covered entity under Section 340B of the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>federal Public Health Service Act, 42 U.S.C. 256b(a)(4).</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B drug" means a drug that has been subject to any offer </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>for reduced prices by a manufacturer pursuant to 42 U.S.C. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>256b and is purchased by a 340B covered entity. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B drug discount program" means the program established </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>under Section 340B of the federal Public Health Service Act, </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>42 U.S.C. 256b.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"340B grantee" means an entity in Illinois that qualifies </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>as a covered entity under subparagraphs (A)–(K) of paragraph </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>(4) of subsection (a) of Section 340B of the federal Public </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>Health Service Act, 42 U.S.C. 256b(a)(4)(A)-(K).</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Critical Access Hospital" has the meaning given to that </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>term in paragraph (4) of subsection (b) of Section 5-5e of the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Illinois Public Aid Code.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Hospital" means a hospital licensed under the Hospital </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>Licensing Act or University of Illinois Hospital Act.</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Manufacturer" or "Pharmaceutical Manufacturer" has the </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>meaning given to the term "manufacturer" in the Wholesale Drug </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>Distribution Licensing Act. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Person" includes a natural person, partnership, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>association, corporation, or any other legal business entity. </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>"Person" does not include any federal or State government </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>entity or body.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>"Safety-Net Hospital" has the meaning given to that term </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>in Section 5-5e.1 of the Illinois Public Aid Code.</code><br> </td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 15. </code><code>Protection of patient access to pharmacy.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) No person, including a pharmaceutical manufacturer, </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>may deny, restrict, prohibit, condition, or otherwise </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>interfere with, either directly or indirectly, the acquisition </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>of a 340B drug by, or delivery of a 340B drug to, a 340B </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>covered entity or a 340B contract pharmacy authorized to </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>receive 340B drugs on behalf of the 340B covered entity unless </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>the receipt is prohibited by federal law.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) No person, including a pharmaceutical manufacturer, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>may impose any restriction on the ability of a 340B covered </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>entity to contract with or designate a 340B contract pharmacy, </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>including restrictions relating to the number, location, </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>ownership, or type of 340B contract pharmacy.</code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) No person, including a pharmaceutical manufacturer, </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>may require or compel a 340B covered entity or 340B contract </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>pharmacy to:</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) submit or otherwise provide ingredient cost or </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>pricing data pertinent to 340B drugs unless required by </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>State or federal law;</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) institute requirements in any way relating to how </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >    <code>a 340B covered entity manages its inventory of 340B drugs </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>that are not required by a State or federal agency, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >    <code>including requirements relating to the frequency or scope </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>of audits of inventory management systems of a 340B </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>covered entity or a 340B contract pharmacy; or</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) submit data or information that is not required by </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>a State or federal law as a condition for a 340B covered </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>entity, its 340B contract pharmacy, or a location </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>otherwise authorized by a 340B covered entity to receive </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>340B drugs.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(d) Each individual transaction, as defined in 21 U.S.C. </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>360eee-24, of 340B drugs that is subject to a prohibited act in </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>subsections (a) and (b) shall constitute a separate violation </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>of this Act.</code><br> </td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 20. </code><code>Reporting. </code><code>On or before August 1, 2026 and </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>each August 1 thereafter, a 340B covered entity shall submit a </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>report to the General Assembly pursuant to this Section. For </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>the purposes of this Section, the following covered entities </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>are exempt until January 1, 2029 and will report on or before </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>August 1, 2029 and each August 1 thereafter: hospitals with </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>fewer than 100 licensed beds, Critical Access Hospitals, </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>Safety-Net Hospitals, and 340B grantees. The report must </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>include all of the following for the 340B covered entity's </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>340B program:</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the name of the 340B covered entity submitting the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >    <code>report;</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) a copy of the 340B covered entity's annual 340B </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >    <code>program recertification;</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) whether a community benefits plan report is </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >    <code>required under Section 20 of the Community Benefits Act </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >    <code>and, if so, a copy of the 340B covered entity's community </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >    <code>benefits plan report, including a description of the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >    <code>amount of charity care provided by the 340B covered </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>entity;</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) the aggregate acquisition cost for prescription </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >    <code>drugs obtained under the 340B program and dispensed or </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>administered to patients;</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(5) the aggregate payment amount received for all </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >    <code>drugs obtained under the 340B program and dispensed or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>administered to patients;</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(6) the number of claims for prescription drugs </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>received under the 340B program;</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(7) the percentage of the 340B covered entity's claims </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>that were for prescription drugs obtained under the 340B </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>program;</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(8) a description of any adverse 340B program audits </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>within the preceding 12 months; and</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(9) a description of the impact of the 340B program on </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>the patients and the community served by the 340B covered </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >    <code>entity.</code><br> </td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 25. </code><code>Medicaid study.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) By January 1, 2028, the Department of Healthcare and </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>Family Services shall report to the General Assembly on the </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>following for the total aggregated covered outpatient drug </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>units dispensed or administered in this State for the prior </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>calendar year in connection with the medical assistance </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>program under the Illinois Public Aid Code, categorized by (i) </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>fee-for-service and (ii) each managed care plan: </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) the number of dispensed or administered covered </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >    <code>outpatient drug units; </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) the number of dispensed or administered covered </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >    <code>outpatient drug units that were subject to a rebate under </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >    <code>42 U.S.C. 1396r-8; and</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) a reasonable estimate of net costs or savings to </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center">- 7 -</td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >    <code>the State's medical assistance program due to 340B covered </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >    <code>entity purchases of covered outpatient drug units at 340B </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >    <code>pricing. </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) To the extent the Department of Healthcare and Family </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Services lacks information to provide a data element required </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>under subsection (a), it shall provide a reasonable estimate </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>based on all available information and an explanation of the </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>information that it lacks.</code><br> </td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 30. </code><code>340B prescription drug applicability. </code><code>Each </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>340B covered entity shall dispense or administer 340B drugs </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>only when in connection with an outpatient health care service </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>received by the patient within the last 18 months.</code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 35. </code><code>Preventing duplication of 340B discounts. </code><code>Each </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>340B covered entity shall develop and maintain a policy that </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>ensures it is not placing an order for a 340B drug to replenish </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>a prior pharmacy dispense if any other 340B covered entity </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>will place an order for a 340B drug to replenish the same prior </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>pharmacy dispense. The policy shall also include a process to </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>reimburse a manufacturer for any duplicate 340B discount the </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>covered entity receives. The policy shall be filed annually </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>with the General Assembly.</code><br> </td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 40. </code><code>Enforcement.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) The Attorney General is authorized to enforce this Act </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center">- 8 -</td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>under its general authority under the Attorney General Act.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) Upon finding a violation of Section 15 of this Act, a </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>court may order:</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) temporary, preliminary, or permanent injunctive </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >    <code>relief for any act, policy, or practice that violates this </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >    <code>Act;</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) money damages to be paid to the 340B covered </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >    <code>entity as a result of the violation of this Act;</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(3) the assessment of a civil penalty of up to $1,000 </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >    <code>for each violation of Section 15; or</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(4) any other relief.</code><br> </td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 45. </code><code>Preemption. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(a) Nothing in this Act shall be construed or applied to be </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>less restrictive than federal law for a person regulated by </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>this Act.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(b) Nothing in this Act shall be construed or applied in a </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>manner that would conflict with:</code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(1) applicable federal law; or</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>    </code><code>    </code><code>(2) other laws of this State if the State law is </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >    <code>compatible with applicable federal law.</code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>    </code><code>(c) Limited distribution of a drug required under 21 </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>U.S.C. 355-1 may not to be construed as a violation of this </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>Act.</code><br> </td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 97. </code><code>Severability. </code><code>If any provision of this Act or </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">10400HB2371sam002</td><td class="xsl" align="center">- 9 -</td><td class="xsl" align="right">LRB104 06098 BAB 26897 a</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>its application to any person or circumstance is held invalid, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>the invalidity of that provision or application does not </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>affect other provisions or applications of this Act that can </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>be given effect without the invalid provision or application. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Each paragraph defining "340B contract pharmacy" in Section 10 </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>is severable.</code><br> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>Section 99. </code><code>Effective date. </code><code>This Act takes effect upon </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>becoming law.".</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
